Yasuo Katayama1, Kazuhiro Usuda, Yasuhiro Nishiyama
1Second Department of Internal Medicine, Nippon, Medical School.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Post-stroke depression (PSD) is common after ischemic stroke, particularly with left-hemisphere lesions. A new selective serotonin reuptake inhibitor (SSRI), fluvoxamine maleate, effectively treated PSD without impacting cerebral blood flow.
Area of Science:
Context:
Purpose:
Summary:
Impact: